JinliangXing Fourth Military Medical UniversityChina

Xing Jinliang Professor, supervisor of Ph.D PI of the State Key Laboratory of Tumor Biology Director of the Department of Physiology and Pathophysiology, Basic Medical College of Air Force Medical University Visiting scholar at M.D. Anderson Cancer Center and Thomas Jefferson University Executive Director of China Anti-Cancer Association (CACA) Chairman of Holistic Integrative Oncology (HIO) Honorary Chairman of Tumor Bio-marker (TBM) Prof. Jinliang Xing is mainly engaged in tumor mitochondrial biology and the transformation of related tumor markers.. Prof. Xing has undertaken more than 30 national science and technology fund key projects, key international cooperation and other topics. The total of more than 160 SCI articles were published, and more than 100 SCI articles (21 if>10) were published as the first and corresponding author in J Natl Cancer Inst, Journal of hepatology, EMBO J, Ann Oncol, Clin Chem, Clin and Mol Hepatology, Gut and other magazines. Authorized and applied for 11 domestic and international invention patents and software copyrights. Edited or participated in editing 14 monographs. Prof. Xing has won 1nd prize of the national science and Technology Progress Award, 1 12th China Patent Award, 2st prizes of the science and technology award of the China anticancer association, 1st prize of Shaanxi Natural Science Award, and 1st prize of Shaanxi science and Technology Progress Award. Prof. Xing won the China Young Scientist Award for oncology in 2018, and was selected as the national candidate of the new century hundred thousand talents project in 2020. Prof. Xing was selected into the list of highly cited Chinese researchers by Elsevier. Currently in 2023.